Home > Newsletters > Drug Industry Daily > CDER Proposes Supersizing Office of Generic Drugs, Mulls New Pharma Quality Office
Drug Industry Daily
Sept. 10, 2012 | Vol. 11 No. 177
CDER Proposes Supersizing Office of Generic Drugs, Mulls New Pharma Quality Office
CDER is looking to elevate the Office of Generic Drugs (OGD) into a “super” office, a move necessitated by the recent passage of the Generic Drug User Fee Amendments (GDUFA) and a heightened public focus on generic medicines, Center Director Janet Woodcock said Friday.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.